GENERAL SESSIONS AND BREAKOUTS
Intersectionality & Clinical Trials: The Role of Procurement
With the global pandemic, diversity, equity, and inclusion spotlights and FDA diversity requirements in clinical trials, challenges to resources, changes in the economy, etc., companies are changing the way they structure and run clinical trials, and R&D Procurement is helping to lead the way. We will learn from two leaders in this space how pharma and bio pharma are meeting these challenges.
Health Equity: Bridging the Disparity Gap
At our East 2022 event we learned about Health Equity, and what it means to healthcare corporations and the communities they serve. During this panel discussion, we will learn what actions corporations are taking to improve health equity, and how health equity ties to supplier diversity.
Scope 3 – Where do you Start?
Corporations, Governments, and regulating bodies are requiring suppliers to set ambitious scope 3 targets. This panel will discuss solutions and resources available to suppliers at no cost.
Barry Kull, Sr.
Sustainability: what Corporations want and how to get started
Corporations demand their partners to develop new sustainable products and services to improve the sustainability of the supply chain. The panel will discuss procurement requirements, resources available to suppliers and share insights from two suppliers’ real-life experiences.
Corporate leaders are confronting a growing list of environmental and social issues that pose serious risks and opportunities for their businesses. They are looking to their suppliers to contribute to the value chain and help them meet their public commitments. Suppliers need the skills, knowledge, and tools to build an organization that has sustainable and innovative solutions to challenges such as climate change and societal inequities. Learn about the trends driving this new business imperative and how to incorporate the important environmental, social and governance (ESG) dimensions of sustainable business practice.
- What is Sustainability and Why it is Important, and Why now
- Growing Supplier Expectations by the Corporates
- Sharing best practice how suppliers start and enhance their sustainability journey
Innovations and Trends in AI
According to estimates, the healthcare AI market will grow to over $45 billion by 2026. Now is the time for everyone involved in healthcare, including medical consumers and entrepreneurs, to understand and embrace the AI in healthcare revolution.
In this session we will explore Innovations and Trends in AI in the Pharma, Biotech, Life Sciences and Healthcare industry segment.
We will explore some new technologies like Cognitive Digital Twin, Large Language Models ( GPT-4), Generative AI and their impact on Supply Chain, Clinical Trials, Drug Discovery, Patient Engagement and Health Equity.
Participants will learn how AI can be leveraged in their business environment.